Latest Commercialization News

DGL Group has addressed ASX concerns following a disclaimer of opinion in its FY25 audit, citing inventory valuation issues and a fraud incident. The company outlines ongoing remediation efforts including ERP system migration and enhanced controls.

First Graphene Limited has raised A$3.5 million through a share placement to accelerate the commercial adoption of its PureGRAPH graphene products and support ongoing operations.

RocketBoots Limited has renewed its pivotal contract with a major Australian retailer, extending an eight-year partnership and securing upfront cash payments. The company also anticipates additional inflows from banking sector pilots and R&D tax incentives, underpinning its growth trajectory.

NeuroScientific Biopharmaceuticals has initiated treatment of its fourth patient under the Special Access Scheme for StemSmart™, progressing towards a Phase 2 trial targeting severe Crohn’s disease.

Dotz Nano has successfully scaled up production of its proprietary CO₂ capture sorbents to kilogram volumes, setting the stage for commercial partnerships and cost efficiencies in the growing carbon capture market.

Barton Gold Holdings has bolstered its cash reserves to an estimated $20 million following a successful $15 million institutional placement and a $660,000 Share Purchase Plan, positioning the company to advance key gold development projects in South Australia.

Commonwealth Bank of Australia reported a 33 basis point increase in its CET1 capital ratio for Q3 2025, driven by earnings growth despite a rise in risk-weighted assets. Liquidity and leverage metrics remain robust, underscoring the bank's resilient capital position.

Downer EDI Limited has landed a substantial $750 million contract with Chevron Australia to provide maintenance and support services at key Western Australian energy facilities over up to 15 years.

Intelligent Monitoring Group (IMG) reported robust FY25 results with $38.4m EBITDA and an 8.2% earnings rise, while projecting up to 24% EBITDA growth in FY26 fueled by AI innovations and key acquisitions.

Optiscan Imaging has entered a three-year strategic collaboration with Australian Clinical Labs to validate and deploy its InForm™ digital pathology platform, aiming to transform diagnostic workflows with real-time tissue analysis.

Eden Innovations has raised $4.35 million through a placement of shortfall shares, marking a key step in its financial reconstruction and global commercialisation plans.

Eden Innovations has successfully raised $4.35 million through a placement of shortfall securities, marking a key step in its financial reconstruction and global expansion plans.